Medical Pathology Quiz (Cardio): Key Questions on Heart Failure

Heart Failure (HF) is one of those dense Medical Pathology topics that can make or break your exam. Between the classifications (preserved vs. reduced EF), diagnostic criteria, and the pharmacological maze, it's easy to get lost. But don't worry, you're in the right place. The best way to solidify your knowledge and spot your weak points is by testing yourself with Active Recall. This practice test, designed for 4th-year medical students like you, is the first step to mastering it. Let's get to it!

Test Yourself: Heart Failure Quiz

1. A 68-year-old patient with a history of myocardial infarction presents with progressive dyspnea. On physical examination, a third heart sound (S3) is auscultated. What is the most likely pathophysiological significance of this finding in the context of Heart Failure? a) Concentric ventricular hypertrophy. b) Aortic valve stenosis. c) Volume overload and systolic dysfunction. d) Severe diastolic dysfunction with a stiff ventricle.

2. Which of the following drugs has been shown to reduce mortality in patients with Heart Failure with PRESERVED Ejection Fraction (HFpEF)? a) Bisoprolol. b) Enalapril. c) Spironolactone. d) Dapagliflozin.

3. What is the primary mechanism of action of Sacubitril, a component of the drug Sacubitril/Valsartan (ARNI)? a) It blocks angiotensin II receptors. b) It inhibits the angiotensin-converting enzyme (ACE). c) It inhibits neprilysin, increasing the levels of natriuretic peptides. d) It blocks sodium channels in the proximal convoluted tubule.

4. A 75-year-old patient is diagnosed with Heart Failure. An NT-proBNP test is ordered, and the result is 2,500 pg/mL. What is the main utility of this biomarker in this context? a) It is the most specific marker for differentiating ischemic heart disease from dilated cardiomyopathy. b) Its elevated value supports the diagnosis of HF and has a high negative prognostic value. c) It is used to immediately monitor the response to diuretic treatment. d) A value above 2,000 pg/mL is a diagnostic criterion for acute myocardial infarction.

5. In the management of a patient with Acute Heart Failure who presents as "warm and wet" (Forrester Class II), what would be the first therapeutic measure? a) Start a beta-blocker like carvedilol. b) Administer a positive inotrope like dobutamine. c) Administer intravenous loop diuretics. d) Administer a vasopressor like norepinephrine.

6. What is the most common etiological cause of Heart Failure with Reduced Ejection Fraction (HFrEF) in developed countries? a) Chronic arterial hypertension. b) Idiopathic dilated cardiomyopathy. c) Ischemic heart disease. d) Aortic valve disease.

7. A patient with known HFrEF (LVEF 30%) reports that he can walk two blocks on flat ground before feeling dyspnea, but gets fatigued climbing one flight of stairs. According to the NYHA functional classification, what class would he be in? a) Class I b) Class II c) Class III d) Class IV

8. The term "ventricular remodeling" in the pathophysiology of Heart Failure refers to: a) The functional recovery of the myocardium after an infarction. b) The changes in the ventricle's geometry and structure (dilation and hypertrophy) in response to overload. c) The formation of fibrotic scar tissue exclusively in the infarct zone. d) The process of accelerated atherosclerosis in the coronary arteries.

9. Which of the following drug classes is part of the "four pillars" of HFrEF treatment, regardless of whether the patient is diabetic or not? a) Calcium channel blockers. b) SGLT2 inhibitors (iSGLT2). c) Statins. d) Class III antiarrhythmics.

10. Diastolic dysfunction is the fundamental pathophysiological mechanism in: a) Dilated cardiomyopathy. b) Heart failure with reduced ejection fraction (HFrEF). c) Heart failure with preserved ejection fraction (HFpEF). d) Post-infarction cardiogenic shock.

---

How did it go? The reasoned solutions are below. If you missed more than 3, you need to review your notes. HF is complex, and the details make the difference between passing and getting top marks.

Answers and Explanations

1. Correct answer: c) Volume overload and systolic dysfunction.

• Explanation: The third heart sound (S3) is caused by rapid and abrupt ventricular filling into an already dilated ventricle with increased end-diastolic volume. It's a classic sign of decompensation in HF with systolic dysfunction (HFrEF).

2. Correct answer: d) Dapagliflozin.

• Explanation: Until recently, no drug had been shown to reduce mortality in HFpEF. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin and empagliflozin (DELIVER and EMPEROR-Preserved trials), have been the first to demonstrate a significant reduction in hospitalizations and cardiovascular death in this patient group.

3. Correct answer: c) It inhibits neprilysin, increasing the levels of natriuretic peptides.

• Explanation: Neprilysin is an enzyme that degrades natriuretic peptides (BNP, ANP). By inhibiting it, Sacubitril increases the half-life of these peptides, enhancing their beneficial effects (vasodilation, natriuresis). It is combined with Valsartan (an ARB) to simultaneously block the renin-angiotensin-aldosterone system.

4. Correct answer: b) Its elevated value supports the diagnosis of HF and has a high negative prognostic value.

• Explanation: NT-proBNP is released by myocytes in response to ventricular wall stress. It has a very high negative predictive value (if it's low, it's very unlikely the dyspnea is due to HF). When elevated, it supports the diagnosis, and higher levels indicate a worse prognosis.

5. Correct answer: c) Administer intravenous loop diuretics.

• Explanation: A "warm and wet" patient is well-perfused (warm) but congested (wet). The cornerstone of initial treatment is to relieve congestion with loop diuretics (like furosemide) to force volume removal.

6. Correct answer: c) Ischemic heart disease.

• Explanation: Coronary artery disease, especially after a myocardial infarction, is the main cause of myocardial damage leading to systolic dysfunction and the development of HFrEF in the Western world.

7. Correct answer: c) Class III.

• Explanation: The NYHA classification is based on the limitation of physical activity. Class II is a slight limitation (dyspnea with ordinary activity), while Class III is a marked limitation (dyspnea with less than ordinary physical activity, like walking a short distance). Class IV is dyspnea at rest.

8. Correct answer: b) The changes in the ventricle's geometry and structure (dilation and hypertrophy) in response to overload.

• Explanation: Remodeling is a deleterious process where the heart tries to compensate for the initial damage, but in the long term, these changes (dilation, hypertrophy, fibrosis) worsen cardiac function and prognosis. Much of the pharmacological treatment aims to reverse or halt this remodeling.

9. Correct answer: b) SGLT2 inhibitors (iSGLT2).

• Explanation: The current four pillars of treatment that modify the prognosis in HFrEF are: 1) ACEi/ARB or ARNI, 2) Beta-blockers, 3) Mineralocorticoid receptor antagonists (MRAs, like spironolactone), and 4) SGLT2i. The latter have demonstrated cardiovascular benefit regardless of the presence of diabetes.

10. Correct answer: c) Heart failure with preserved ejection fraction (HFpEF).

• Explanation: In HFpEF, the main problem is not contraction (systole), which is preserved (LVEF >50%), but rather relaxation and ventricular filling (diastole). The ventricle becomes stiff and hypertrophied, making it difficult to fill and increasing filling pressures.

Where Students Usually Go Wrong with Heart Failure

1. Confusing the pathophysiology of HFpEF vs. HFrEF: It's crucial to understand that HFrEF is a "pumping" problem (systolic dysfunction) and HFpEF is a "filling" problem (diastolic dysfunction). This affects both the clinical presentation and the treatment.
2. Using drugs in Acute HF: A classic mistake is wanting to start a beta-blocker for a patient in the middle of an acute decompensation ("wet"). Wrong! Beta-blockers are for chronic, stable management; in an acute setting, they can worsen the situation if the patient isn't euvolemic and stable.
3. Interpreting NT-proBNP without context: Thinking it's a magic number. You have to remember that its levels can be falsely low in obese patients or elevated in other conditions like old age, atrial fibrillation, or renal failure. Clinical context is king.

Is Your Exam Different?

This quiz covers the cornerstones of Heart Failure according to clinical guidelines and reference manuals. But let's be honest: your exam won't be written by a clinical guideline. It will be written by your professor.

And every professor has their favorite topics, recurring questions, and their own particular way of approaching the subject. Maybe they focus more on the Forrester classification for acute HF, or on the details of the PARADIGM-HF trial. How do you prepare for that?

This is where a generic quiz falls short. The only way to train for your real exam is to practice with questions based on YOUR syllabus. Upload your Heart Failure notes to Smartests and our AI will create a 100% personalized practice test for you. Stop studying for a generic exam and start preparing to PASS yours.

Generate my personalized test now

Quick Summary

Today you've reviewed and tested your knowledge on:

• The four pharmacological pillars that have been shown to change the prognosis in HFrEF.
• The fundamental difference between systolic (HFrEF) and diastolic (HFpEF) dysfunction.
• The central role of NT-proBNP and key signs like S3 in the diagnosis and prognosis of HF.